Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
Go back to Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 14.41 +0.07 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.34 | 52 Week High | $12.48 | |||
| Open | $14.17 | 52 Week Low | $1.60 | |||
| Day High | $14.49 | P/E | N/A | |||
| Day Low | $13.95 | EPS | $-6.33 | |||
| Volume | 3,498,149 | |||||

